Nu-Med Plus, Inc. (NUMD): Operating Cash Flow
-$48.0K
Year ended 2025-12-31
-$51.7K
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$48.0K | n/m | 2026-04-15, From 2025-01-01 |
| 2024-12-31 | -$4.4K | n/m | 2026-04-15, From 2024-01-01 |
| 2023-12-31 | -$66.4K | n/m | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | -$38.5K | n/m | 2024-03-26, From 2022-01-01 |
| 2021-12-31 | -$206.8K | n/m | 2023-04-03, From 2021-01-01 |
| 2020-12-31 | -$414.8K | n/m | 2022-04-11, From 2020-01-01 |
| 2019-12-31 | -$567.3K | n/m | 2021-03-31, From 2019-01-01 |
| 2018-12-31 | -$467.6K | n/m | 2020-03-30, From 2018-01-01 |
| 2017-12-31 | -$430.5K | n/m | 2019-04-01, From 2017-01-01 |
| 2016-12-31 | -$180.3K | n/m | 2018-04-03, From 2016-01-01 |
| 2015-12-31 | -$182.9K | n/c | 2017-04-19, From 2015-01-01 |
| 2014-12-31 | -$158.3K | n/m | 2016-04-13, From 2014-01-01 |
| 2013-12-31 | -$140.5K | n/m | 2015-03-23, From 2013-01-01 |
| 2012-12-31 | -$104.2K | n/a | 2014-02-21, From 2012-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Nu-Med Plus, Inc. (NUMD) | 2025-12-31 | -$48.0K | n/m |
| RetinalGenix Technologies Inc. (RTGN) | 2025-12-31 | -$558.4K | n/m |
| ALR Technologies SG Ltd. (ALRTF) | 2025-12-31 | -$1.87M | n/m |
| Odyssey Health, Inc. (ODYY) | 2025-07-31 | -$347.4K | n/m |
| Stimcell Energetics Inc. (STME) | 2026-05-31 | -$312.1K | n/m |
| Global Innovative Platforms Inc. (GIPL) | 2025-09-30 | -$560.7K | n/m |
| Sigyn Therapeutics, Inc. (SIGY) | 2024-12-31 | -$872.4K | n/m |
| Vycor Medical Inc (VYCO) | 2025-12-31 | -$13.5K | n/m |
| Mountain Crest Acquisition Corp. V (MCAG) | 2025-12-31 | -$742.0K | n/m |
Compare NUMD, RTGN, ALRTF, ODYY side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗